Moneycontrol PRO
Loans
HomeNewsFortishealthcare
Jump to
  • IHH CEO says top priority is to stablise and secure Fortis Healthcare

    IHH CEO says top priority is to stablise and secure Fortis Healthcare

    Tan said IHH has developed a 100-day turnaround plan to improve the operating margins by around 500-600 basis points.

  • Legacy of Fortis & Manipal coming together is quite positive: Narayana Health

    Legacy of Fortis & Manipal coming together is quite positive: Narayana Health

    In an interview with CNBC-TV18, Ashutosh Raghuvanshi, VC, MD & Group CEO of Narayana Health spoke about the latest happenings in his company and sector.

  • Fortis: No decision on Manipal offer

    Fortis: No decision on Manipal offer

    Fortis Healthcare has received a non-binding indication interest from Manipal Health but no decision has been taken by board on Manipal offer. In an interview with CNBC-TV18, Sandeep Parekh, Founder of Finsec Law Advisors shared his views and outlook on the same.

  • Private sector filling up the vacuum in healthcare facilities: Wockhardt

    Private sector filling up the vacuum in healthcare facilities: Wockhardt

    After a scathing report from the National Pharmaceutical Pricing Authority (NPPA) highlighting huge margin mark ups in corporate hospital Fortis' in patient bills, there has been a growing call for regulating private hospitals. But is it feasible? On the side-lines of a book launch, Wockhardt Hospital’s Chairman Habil Khorakiwala said government is abdicating its responsibility by just expecting to regulate private sector.

  • Demonetisation: Fortis Health sales dip 10-15%; co looks at digital payment mode

    Demonetisation: Fortis Health sales dip 10-15%; co looks at digital payment mode

    Bhavdeep Singh, CEO, Fortis Healthcare says Fortis is looking at other payment options like digital wallets and is doing its best to not turn patients away.

  • SRL likely to be valued 25 times FY18 operating profit:Macquarie

    SRL likely to be valued 25 times FY18 operating profit:Macquarie

    Singhal sees significant opportunity for diagnositics players such as Dr Lal Path Labs, Thyrocare and SRL. Organised players are already gaining market share and companies which maintain quality standards will definitely do well, he says.

  • Won't see any transfer of debt in Fortis re-jig: CEO

    Won't see any transfer of debt in Fortis re-jig: CEO

    The name of Fortis Malar will subsequently be changed to SRK. CNBC-TV18's Varinder Bansal caught up with Bhavdeep Singh, CEO, Fortis Healthcare, to get more details.

  • Fortis to get a makeover, demerge diagnostics business

    Fortis to get a makeover, demerge diagnostics business

    The board of directors of Fortis Healthcare on Friday approved the demerger of its diagnostics business. Fortis will include its diagnostics business into Fortis Malar Hospitals which will later be renamed SRL, the company said in a filing to BSE.

  • Fortis targets 20% EBIDTA margins in next 2-3 years

    Fortis targets 20% EBIDTA margins in next 2-3 years

    The healthcare company will rely on brownfield expansion for driving growth and is also exploring the de-merger or a possible listing of SRL Diagnostics arm, Chief Executive Officer Bhavdeep Singh told CNBC-TV18.

  • See low double-digit growth, two-fold rise in bed count: Fortis

    See low double-digit growth, two-fold rise in bed count: Fortis

    The hospital's occupancy rate is hovering around 72-73%, which Singh claims is higher than the industry. In the diagnostic business, Fortis expects to see margins in the high 20s.

  • To focus on cancer treatment, organ therapy: Fortis Health

    To focus on cancer treatment, organ therapy: Fortis Health

    CEO Bhavdeep says Fortis Healthcare is targetting a 20 percent increase in bed count over the next four to five years, annually.

  • No intent to exit all mkts but focus on India biz: Fortis

    No intent to exit all mkts but focus on India biz: Fortis

    Post divestment the company is expected to cut down its debt to Rs 400 crore from the current Rs 900 crore.

  • Fortis to use proceeds from Dental Corp sale to pare debt

    Fortis to use proceeds from Dental Corp sale to pare debt

    Fortis Healthcare will use the entire proceeds from its 64 percent stake in Dental Corporation Holdings Ltd (DC), Australia to pare debt, says Vishal Bali, Global CEO. The company's stake in DC will be sold to Bupa for 270 million Australian dollar (around Rs 1,554.36 crore) by March 2013.

  • Fortis aims significant debt reduction; to raise Rs 2000cr

    Fortis aims significant debt reduction; to raise Rs 2000cr

    In an interview to CNBC-TV18, Vishal Bali, global chief executive officer, Fortis Healthcare says the company is trying to take a lot of steps to reduce their overall debt. He says a committee has been set to reduce their debt levels.

  • Have raised S$510m through Religare Health Trust: Malvinder

    Have raised S$510m through Religare Health Trust: Malvinder

    Religare Health Trust, backed by Indian hospital chain Fortis Healthcare, has successful raised 510.7 million Singapore dollars in gross proceeds from its initial public offering (IPO) on the Singapore Exchange (SGX).

  • Fortis Health to acquire Fortis Health Intl for $665m

    Fortis Health to acquire Fortis Health Intl for $665m

    Healthcare major Fortis will acquire its Singapore-based arm Fortis Healthcare International for USD 665 million informed, the company’s chairman Malvinder Singh.

  • Fortis looking to go to 8-10 verticals in 10-15 countries

    Fortis looking to go to 8-10 verticals in 10-15 countries

    Fortis Healthcare India today announced an all-cash deal to acquire Fortis Healthcare International as part of its plan to merge India and international operations. CNBC-TV18 catches up with the Singh brothers, Malvinder and Shivinder Singh, to understand the rationale behind the deal and the way forward for the merged entity.

  • Merged unit will create excellent synergy: Malvinder Singh

    Merged unit will create excellent synergy: Malvinder Singh

    Hospital chain Fortis Healthcare (India) will buy Singapore-based sister firm Fortis Healthcare International in a move to bring all of the group's health businesses under one firm, group Chairman Malvinder Singh said.

  • Fortis to get footprint in Vietnam market via new deal

    Fortis to get footprint in Vietnam market via new deal

    Malvinder Singh, chairman of Fortis Healthcare said that this deal will make the company one of the leading international healthcare delivery service companies in this marked space.

  • Healthcare service tax may be passed onto customers: Fortis

    Healthcare service tax may be passed onto customers: Fortis

    Malvinder Singh, Chairman, Fortis Healthcare, in an interview on CNBC-TV18 gave his views on how he read the budget presented by finance minister Pranab Mukherjee for financial year 2011-12.

  • Fortis buys cancer hospital in Singapore for Rs 115cr

    Fortis buys cancer hospital in Singapore for Rs 115cr

    Fortis' second attempt to enter Singapore has proved to be successful. Fortis Global Healthcare Holdings acquired an under construction specialised cancer hospital in Singapore.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347